1.170USD-1.68%Mkt Cap: 13.43M $P/E: —1d ago
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers …
Industry Peers
Medical Instruments & SuppliesIndicators:|
Key Statistics
Company
Market Cap13.43M $
Enterprise Value16.03M $
Revenue (TTM)28.74M $
Gross Profit13.19M $
Net Income (TTM)-26.39M $
Revenue/Share3.823 USD
Last Price1.170 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees95
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.05
PEG—
EV/EBITDA-0.69
EV/Revenue0.56
P/S0.47
P/B0.35
EPS (TTM)-4.46
EPS (Forward)-1.11
52W Range
1.0602% of range5.500
52W High5.500 USD
52W Low1.060 USD
Profitability
Gross Margin46.25%
Oper. Margin-118.09%
EBITDA Margin-81.31%
Profit Margin-92.59%
ROE-59.42%
ROA-35.87%
Growth
Revenue Growth3.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.34M $
CapEx (TTM)—
FCF Margin-23.12%
FCF Yield-49.48%
Net Debt2.61M $
Net Debt/EBITDA-0.11
Balance Sheet
Debt/Equity0.16
Current Ratio1.84
Quick Ratio0.87
Book Value/Sh3.322 USD
Cash/Share1.255 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:60
Split DateJan 27, 2025
Analyst Consensus
Rating—
Target (Mean)5.000 USD
Upside (mean)+327.4%
Target Range4.000 USD – 6.000 USD
$4.000+327.4% to mean$6.000
# Analysts2
Ownership
Shares Out.11.47M
Float10.34M
Insiders7.41%
Institutions10.12%
Short Interest
Short Ratio7.8d
Short % Float10.09%
Short % Out.10.09%
Shares Short1.16M
Short (prev mo.)1.12M
Technical
SMA 501.195 (-2.1%)
SMA 2001.402 (-16.5%)
Beta1.62
S&P 52W Chg20.25%
Avg Vol (30d)136.94K
Avg Vol (10d)126.84K
Technical Indicators
RSI (14)50.1
MACD-0.0047
MACD Signal-0.0104
MACD Hist.+0.0057
BB Upper1.194 USD
BB Middle1.154 USD
BB Lower1.114 USD
BB Width6.97%
ATR (14)0.0437 USD
Vol Ratio (20d)0.33x